GSK (GSK) News Today → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free GSK Stock Alerts GBX 1,615 -14.00 (-0.86%) (As of 04:59 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5, 2024 | americanbankingnews.comGSK (LON:GSK) Earns Underweight Rating from JPMorgan Chase & Co.June 4, 2024 | marketbeat.comGSK (LON:GSK) Receives Underweight Rating from JPMorgan Chase & Co.JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a research note on Tuesday.June 3, 2024 | americanbankingnews.comGSK plc (LON:GSK) Receives Consensus Rating of "Hold" from BrokeragesMay 28, 2024 | finance.yahoo.comCureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSKMay 25, 2024 | marketwatch.comGSK Says Illinois Jury Finds Heartburn Drug Zantac Not Liable for Plaintiff's CancerMay 24, 2024 | markets.businessinsider.comGSK: Court Finds In GSK's Favour In First Zantac Case To Go To TrialMay 23, 2024 | msn.comPotential blockbuster asthma drug met goals in trials, GSK saysMay 23, 2024 | msn.comBoost for GSK as US court rejects woman's claims heartburn drug Zantac caused her cancerMay 23, 2024 | msn.comGSK says its experimental drug reduced asthma attacks with only two doses a yearMay 21, 2024 | finance.yahoo.comGSK’s New Vaccine Kept the Boss in Her Job — and an Activist at BayMay 21, 2024 | finance.yahoo.comGSK Sees Positive Results for Severe Asthma Treatment DepemokimabMay 20, 2024 | msn.comGSK faces whistleblower lawsuit over Zantac cancer riskMay 20, 2024 | msn.comGSK Faces Whistleblower Suit From Lab That Found Zantac RiskMay 16, 2024 | lse.co.ukTOP NEWS: GSK to sell remaining holding in spin-off HaleonMay 16, 2024 | msn.comGSK to sell entire Haleon stakeMay 15, 2024 | msn.comGSK chief calls for more investment to combat drug-resistant bacteriaMay 14, 2024 | finanznachrichten.deThe Department of Health - Abu Dhabi: Department of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution HubMay 14, 2024 | finance.yahoo.comDepartment of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution HubMay 9, 2024 | forbes.comBuy Write Grabs Next Week’s Dividend From GSKMay 9, 2024 | finance.yahoo.comGSK (LON:GSK) Is Paying Out A Dividend Of £0.15May 8, 2024 | marketbeat.comGSK (LON:GSK) Reaches New 12-Month High at $1,767.50GSK (LON:GSK) Sets New 12-Month High at $1,767.50May 7, 2024 | marketbeat.comGSK's (GSK) Equal Weight Rating Reiterated at BarclaysBarclays reiterated an "equal weight" rating and issued a GBX 1,725 ($21.67) price objective on shares of GSK in a research report on Tuesday.May 6, 2024 | finance.yahoo.comGSK Stock Today: Buying An August Covered Call Boosts Your Return By This MuchMay 5, 2024 | finance.yahoo.comGSK plc (NYSE:GSK) Q1 2024 Earnings Call TranscriptMay 2, 2024 | bloomberg.comGSK, Boehringer Put Profits Over User Safety, Zantac Jury ToldMay 2, 2024 | msn.comModerna to seek parity for RSV shot as rivals lead in marketMay 2, 2024 | marketbeat.comGSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their price objective on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an "underweight" rating in a research note on Thursday.May 2, 2024 | marketbeat.comGSK (LON:GSK) Sets New 1-Year High After Dividend AnnouncementGSK (LON:GSK) Sets New 12-Month High After Dividend AnnouncementMay 1, 2024 | marketbeat.comGSK plc (LON:GSK) to Issue GBX 15 DividendGSK plc (LON:GSK) declared a dividend on Wednesday, May 1st. Investors of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share on Thursday, July 11th. This represents a yield of 0.9%. The ex-dividend date of this dividend is Thursday, May 16th. The official announcement can be seen at this link.May 1, 2024 | marketbeat.comGSK (LON:GSK) Earns Buy Rating from Shore CapitalShore Capital reiterated a "buy" rating on shares of GSK in a report on Wednesday.May 1, 2024 | morningstar.comGSK Lifts Guidance After Turnover Beats Expectations — UpdateMay 1, 2024 | msn.comGSK Non-GAAP EPS of 43.10p, revenue of £7.4B; updates FY24 outlookApril 30, 2024 | finance.yahoo.comGenomics plc and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial designApril 30, 2024 | marketwatch.comGSK Turnover, Net Profit Expected to Rise as Investors Seek Zantac Litigation Clarity -- Earnings PreviewApril 24, 2024 | msn.comSCI, GSK launches $1m initiative to boost immunisation rate in Nigeria, EthiopiaApril 24, 2024 | msn.comUS regulator accepts GSK’s application to expand treatment of cancer drugApril 24, 2024 | ft.comGSK readies for pivotal ruling in Zantac casesApril 19, 2024 | seekingalpha.comGSK Trades At Low Price Multiples, But Its Pipeline Needs To ImproveApril 18, 2024 | finance.yahoo.comGSK Canada expands charitable partnerships to include support of environmental sustainability and STEMApril 17, 2024 | marketbeat.comDeutsche Bank Aktiengesellschaft Reaffirms "Buy" Rating for GSK (LON:GSK)Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 1,950 ($24.27) target price on shares of GSK in a research note on Wednesday.April 16, 2024 | finance.yahoo.comGSK May 2024 28.000 call (GSK240517C00028000)April 16, 2024 | seekingalpha.comLyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data CatalystsApril 16, 2024 | finance.yahoo.comBrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwnApril 16, 2024 | lse.co.ukGSK's latest meningitis vaccine accepted for review by US regulatorApril 16, 2024 | markets.businessinsider.comFDA Accepts GSK's 5-in-1 Meningococcal ABCWY Vaccine Candidate For Regulatory ReviewApril 14, 2024 | marketbeat.comGSK plc (LON:GSK) Given Average Rating of "Hold" by AnalystsShares of GSK plc (LON:GSK - Get Free Report) have earned a consensus rating of "Hold" from the seven brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have givenApril 12, 2024 | finance.yahoo.comGSK plc: GSK's Strong Vaccine and HIV Portfolios Support Steady GrowthApril 11, 2024 | msn.comWall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend YieldsApril 11, 2024 | msn.comDemocrats push more drug makers to lower the price of inhalersApril 11, 2024 | forbes.comWill Biopharma Companies Shun Vaccine R&D In A New Pandemic? Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.150.77▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼47▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DPH News Today AZN News Today HLN News Today SN News Today CTEC News Today HIK News Today HCM News Today INDV News Today EMIS News Today GNS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored